The Valley Desk

NCT02547805 · Interventional trial

Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days

Overall registry status Completed

Phase 2

Conditions Dietary Hyperoxaluria, Hyperoxaluria, Kidney Stones, Nephrolithiasis, Secondary Hyperoxaluria

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov